Zatloukal Innovations GmbH develops solutions for medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats. In particular, the company will develop GMP-compliant production processes for manufacturing biologics in genetically modified plants, as well as autoinjectors and rapid diagnostic tests for field applications. The research and development work is funded by the EU and private investors and has been awarded the STEP seal.